XML 55 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Apr. 30, 2014
Apr. 30, 2013
Cash Flows From Operating Activities:    
Net income $ 154,777 $ 133,247
Adjustments to reconcile net income to net cash used for operating activities:    
Depreciation and amortization 11,096 11,610
Amortization of deferred sales commissions 9,366 9,591
Stock-based compensation 29,489 26,884
Deferred income taxes 11,123 (1,755)
Net (gains) losses on investments and derivatives 2,909 (6,226)
Equity in net income of affiliates, net of amortization (10,422) (8,127)
Dividends received from affiliates 8,338 10,163
Consolidated CLO entities' operating activities:    
Net (gains) losses on bank loans, other investments and note obligations (853) 2,739
Amortization (665) (403)
Net decrease in other assets and liabilities, including cash (140,520) (29,244)
Changes in operating assets and liabilities:    
Investment advisory fees and other receivables (2,112) (13,692)
Investments in trading securities (178,504) (127,402)
Deferred sales commissions (8,116) (9,516)
Other assets 8,054 32,715
Accrued compensation (72,785) (60,286)
Accounts payable and accrued expenses 8,507 (3,443)
Other liabilities 15,051 (18,947)
Net cash used for operating activities (155,267) (52,092)
Cash Flows From Investing Activities:    
Additions to equipment and leasehold improvements (4,226) (2,158)
Net cash paid in acquisition 0 (86,429)
Cash paid for intangible assets 0 (300)
Proceeds from sales of investments 63,843 63,184
Purchase of investments (20,813) (662)
Consolidated CLO entities' investing activities:    
Proceeds from sales and maturities of bank loans and other investments 332,652 199,601
Purchase of bank loans and other investments (247,649) (85,412)
Net cash provided by investing activities 123,807 87,824
Cash Flows From Financing Activities:    
Purchase of additional non-controlling interest (26,872) (43,507)
Proceeds from issuance of subsidiary equity 0 1,092
Proceeds from issuance of Voting Common Stock 59 0
Proceeds from issuance of Non-Voting Common Stock 32,454 86,536
Repurchase of Voting Common Stock (77) (73)
Repurchase of Non-Voting Common Stock (135,333) (22,723)
Principal repayments on notes receivable from stock option exercises 1,570 1,611
Excess tax benefit of stock option exercises 11,206 13,118
Dividends paid (53,566) (166,980)
Net subscriptions received from (redemptions/distributions paid to) non-controlling interest holders (5,310) 37,189
Consolidated CLO entities' financing activities:    
Repayment of line of credit (247,789) 0
Repayment of redeemable preferred shares (60,000) 0
Issuance of senior and subordinated notes and preferred shares 429,582 0
Principal repayments of senior note obligations (63,780) (83,742)
Net cash used for financing activities (117,856) (177,479)
Effect of currency rate changes on cash and cash equivalents (651) (194)
Net decrease in cash and cash equivalents (149,967) (141,941)
Cash and cash equivalents, beginning of period 461,906 462,076
Cash and cash equivalents, end of period 311,939 320,135
Supplemental Cash Flow Information:    
Cash paid for interest 13,916 16,478
Cash paid for interest by consolidated CLO entities 4,094 7,920
Cash paid for income taxes, net of refunds 51,609 61,016
Supplemental Disclosure of Non-Cash Information:    
Increase in equipment and leasehold improvements due to non-cash additions 28 0
Exercise of stock options through issuance of notes receivable 1,922 4,734
Acquisition of non-controlling interests through issuance of subsidiary equity 9,935 0
Deconsolidations of Sponsored Investment Funds:    
Decrease in investments (776) (14,461)
Decrease in non-controlling interests $ (745) $ (13,969)